nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—CYP1A2—type 2 diabetes mellitus	0.129	0.449	CbGaD
Sulindac—PTGS2—type 2 diabetes mellitus	0.0836	0.291	CbGaD
Sulindac—ALB—type 2 diabetes mellitus	0.0745	0.259	CbGaD
Sulindac—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0304	0.0761	CbGbCtD
Sulindac—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0304	0.0761	CbGbCtD
Sulindac—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.028	0.0702	CbGbCtD
Sulindac—ALB—Gliclazide—type 2 diabetes mellitus	0.0267	0.0668	CbGbCtD
Sulindac—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0266	0.0667	CbGbCtD
Sulindac—ALB—Repaglinide—type 2 diabetes mellitus	0.0251	0.0628	CbGbCtD
Sulindac—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0237	0.0595	CbGbCtD
Sulindac—PTGS1—Nateglinide—type 2 diabetes mellitus	0.023	0.0577	CbGbCtD
Sulindac—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0221	0.0553	CbGbCtD
Sulindac—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0209	0.0524	CbGbCtD
Sulindac—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0202	0.0506	CbGbCtD
Sulindac—ALB—Valsartan—type 2 diabetes mellitus	0.0185	0.0463	CbGbCtD
Sulindac—ALB—Nateglinide—type 2 diabetes mellitus	0.0172	0.0431	CbGbCtD
Sulindac—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0136	0.0342	CbGbCtD
Sulindac—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0125	0.0314	CbGbCtD
Sulindac—SLC22A6—Losartan—type 2 diabetes mellitus	0.0125	0.0312	CbGbCtD
Sulindac—AKR1B1—sciatic nerve—type 2 diabetes mellitus	0.012	0.225	CbGeAlD
Sulindac—ALB—Glyburide—type 2 diabetes mellitus	0.0116	0.0291	CbGbCtD
Sulindac—ALB—Losartan—type 2 diabetes mellitus	0.0106	0.0266	CbGbCtD
Sulindac—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00986	0.0247	CbGbCtD
Sulindac—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00932	0.0234	CbGbCtD
Sulindac—CYP1A2—Losartan—type 2 diabetes mellitus	0.00635	0.0159	CbGbCtD
Sulindac—AKR1B1—peripheral nervous system—type 2 diabetes mellitus	0.0046	0.0864	CbGeAlD
Sulindac—MAPK3—artery—type 2 diabetes mellitus	0.00262	0.0492	CbGeAlD
Sulindac—MAPK3—endothelium—type 2 diabetes mellitus	0.00222	0.0416	CbGeAlD
Sulindac—AKR1B1—islet of Langerhans—type 2 diabetes mellitus	0.00174	0.0326	CbGeAlD
Sulindac—AKR1B1—retina—type 2 diabetes mellitus	0.00149	0.0279	CbGeAlD
Sulindac—AKR1B1—nephron tubule—type 2 diabetes mellitus	0.0014	0.0263	CbGeAlD
Sulindac—PPARD—islet of Langerhans—type 2 diabetes mellitus	0.00137	0.0257	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—type 2 diabetes mellitus	0.00126	0.0236	CbGeAlD
Sulindac—PTGS2—leg—type 2 diabetes mellitus	0.00124	0.0233	CbGeAlD
Sulindac—AKR1B1—kidney—type 2 diabetes mellitus	0.00123	0.0231	CbGeAlD
Sulindac—AKR1B1—pancreas—type 2 diabetes mellitus	0.00122	0.0229	CbGeAlD
Sulindac—AKR1B1—cortex of kidney—type 2 diabetes mellitus	0.0012	0.0225	CbGeAlD
Sulindac—PTGS2—hindlimb—type 2 diabetes mellitus	0.00111	0.0209	CbGeAlD
Sulindac—AKR1B1—adipose tissue—type 2 diabetes mellitus	0.00111	0.0208	CbGeAlD
Sulindac—MAPK3—retina—type 2 diabetes mellitus	0.00108	0.0202	CbGeAlD
Sulindac—MAPK3—nephron tubule—type 2 diabetes mellitus	0.00101	0.019	CbGeAlD
Sulindac—PPARD—pancreas—type 2 diabetes mellitus	0.000961	0.018	CbGeAlD
Sulindac—MAPK3—cardiovascular system—type 2 diabetes mellitus	0.000911	0.0171	CbGeAlD
Sulindac—MAPK3—kidney—type 2 diabetes mellitus	0.000892	0.0167	CbGeAlD
Sulindac—MAPK3—pancreas—type 2 diabetes mellitus	0.000886	0.0166	CbGeAlD
Sulindac—PPARD—adipose tissue—type 2 diabetes mellitus	0.000872	0.0164	CbGeAlD
Sulindac—MAPK3—cortex of kidney—type 2 diabetes mellitus	0.000868	0.0163	CbGeAlD
Sulindac—MAPK3—adipose tissue—type 2 diabetes mellitus	0.000804	0.0151	CbGeAlD
Sulindac—AKR1B1—liver—type 2 diabetes mellitus	0.000777	0.0146	CbGeAlD
Sulindac—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000776	0.0146	CbGeAlD
Sulindac—PTGS1—artery—type 2 diabetes mellitus	0.000713	0.0134	CbGeAlD
Sulindac—PTGS2—artery—type 2 diabetes mellitus	0.000681	0.0128	CbGeAlD
Sulindac—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000664	0.0125	CbGeAlD
Sulindac—PPARD—liver—type 2 diabetes mellitus	0.000611	0.0115	CbGeAlD
Sulindac—PTGS1—endothelium—type 2 diabetes mellitus	0.000602	0.0113	CbGeAlD
Sulindac—PTGS2—endothelium—type 2 diabetes mellitus	0.000575	0.0108	CbGeAlD
Sulindac—MAPK3—liver—type 2 diabetes mellitus	0.000564	0.0106	CbGeAlD
Sulindac—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000327	0.00614	CbGeAlD
Sulindac—CYP1A1—kidney—type 2 diabetes mellitus	0.000276	0.00518	CbGeAlD
Sulindac—ALB—liver—type 2 diabetes mellitus	0.000269	0.00504	CbGeAlD
Sulindac—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000249	0.00466	CbGeAlD
Sulindac—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000248	0.00465	CbGeAlD
Sulindac—PTGS1—kidney—type 2 diabetes mellitus	0.000242	0.00455	CbGeAlD
Sulindac—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000237	0.00444	CbGeAlD
Sulindac—PTGS2—kidney—type 2 diabetes mellitus	0.000232	0.00435	CbGeAlD
Sulindac—PTGS2—pancreas—type 2 diabetes mellitus	0.00023	0.00432	CbGeAlD
Sulindac—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000218	0.0041	CbGeAlD
Sulindac—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000209	0.00392	CbGeAlD
Sulindac—CYP1A2—liver—type 2 diabetes mellitus	0.000177	0.00332	CbGeAlD
Sulindac—CYP1A1—liver—type 2 diabetes mellitus	0.000174	0.00327	CbGeAlD
Sulindac—PTGS2—liver—type 2 diabetes mellitus	0.000146	0.00275	CbGeAlD
Sulindac—Vertigo—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000613	CcSEcCtD
Sulindac—Headache—Pioglitazone—type 2 diabetes mellitus	8.49e-05	0.000613	CcSEcCtD
Sulindac—Syncope—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000612	CcSEcCtD
Sulindac—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.000611	CcSEcCtD
Sulindac—Visual impairment—Ramipril—type 2 diabetes mellitus	8.45e-05	0.00061	CcSEcCtD
Sulindac—Discomfort—Metformin—type 2 diabetes mellitus	8.43e-05	0.000608	CcSEcCtD
Sulindac—Fatigue—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000608	CcSEcCtD
Sulindac—Nausea—Glipizide—type 2 diabetes mellitus	8.4e-05	0.000606	CcSEcCtD
Sulindac—Vomiting—Glimepiride—type 2 diabetes mellitus	8.39e-05	0.000606	CcSEcCtD
Sulindac—Hypotension—Valsartan—type 2 diabetes mellitus	8.39e-05	0.000606	CcSEcCtD
Sulindac—Vision blurred—Losartan—type 2 diabetes mellitus	8.39e-05	0.000605	CcSEcCtD
Sulindac—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.37e-05	0.000604	CcSEcCtD
Sulindac—Constipation—Gliclazide—type 2 diabetes mellitus	8.36e-05	0.000603	CcSEcCtD
Sulindac—Rash—Glimepiride—type 2 diabetes mellitus	8.32e-05	0.000601	CcSEcCtD
Sulindac—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.32e-05	0.0006	CcSEcCtD
Sulindac—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.0006	CcSEcCtD
Sulindac—Rash—Sitagliptin—type 2 diabetes mellitus	8.3e-05	0.000599	CcSEcCtD
Sulindac—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.29e-05	0.000598	CcSEcCtD
Sulindac—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000598	CcSEcCtD
Sulindac—Headache—Glimepiride—type 2 diabetes mellitus	8.27e-05	0.000597	CcSEcCtD
Sulindac—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.26e-05	0.000596	CcSEcCtD
Sulindac—Headache—Sitagliptin—type 2 diabetes mellitus	8.24e-05	0.000595	CcSEcCtD
Sulindac—Anaemia—Losartan—type 2 diabetes mellitus	8.23e-05	0.000594	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.18e-05	0.00059	CcSEcCtD
Sulindac—Oedema—Metformin—type 2 diabetes mellitus	8.18e-05	0.00059	CcSEcCtD
Sulindac—Tinnitus—Ramipril—type 2 diabetes mellitus	8.17e-05	0.00059	CcSEcCtD
Sulindac—Hypertension—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000589	CcSEcCtD
Sulindac—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.15e-05	0.000588	CcSEcCtD
Sulindac—Flushing—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000587	CcSEcCtD
Sulindac—Angioedema—Losartan—type 2 diabetes mellitus	8.13e-05	0.000587	CcSEcCtD
Sulindac—Insomnia—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000586	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.09e-05	0.000583	CcSEcCtD
Sulindac—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.06e-05	0.000582	CcSEcCtD
Sulindac—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.06e-05	0.000581	CcSEcCtD
Sulindac—Myalgia—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000581	CcSEcCtD
Sulindac—Chest pain—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000581	CcSEcCtD
Sulindac—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000581	CcSEcCtD
Sulindac—Shock—Metformin—type 2 diabetes mellitus	8.05e-05	0.000581	CcSEcCtD
Sulindac—Insomnia—Orlistat—type 2 diabetes mellitus	8.03e-05	0.000579	CcSEcCtD
Sulindac—Malaise—Losartan—type 2 diabetes mellitus	8.03e-05	0.000579	CcSEcCtD
Sulindac—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.02e-05	0.000579	CcSEcCtD
Sulindac—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.01e-05	0.000578	CcSEcCtD
Sulindac—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.01e-05	0.000578	CcSEcCtD
Sulindac—Vertigo—Losartan—type 2 diabetes mellitus	8e-05	0.000577	CcSEcCtD
Sulindac—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.99e-05	0.000577	CcSEcCtD
Sulindac—Somnolence—Valsartan—type 2 diabetes mellitus	7.98e-05	0.000576	CcSEcCtD
Sulindac—Syncope—Losartan—type 2 diabetes mellitus	7.98e-05	0.000576	CcSEcCtD
Sulindac—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.97e-05	0.000575	CcSEcCtD
Sulindac—Leukopenia—Losartan—type 2 diabetes mellitus	7.97e-05	0.000575	CcSEcCtD
Sulindac—Discomfort—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000574	CcSEcCtD
Sulindac—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.91e-05	0.000571	CcSEcCtD
Sulindac—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.91e-05	0.00057	CcSEcCtD
Sulindac—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.87e-05	0.000568	CcSEcCtD
Sulindac—Palpitations—Losartan—type 2 diabetes mellitus	7.87e-05	0.000568	CcSEcCtD
Sulindac—Nausea—Glimepiride—type 2 diabetes mellitus	7.84e-05	0.000566	CcSEcCtD
Sulindac—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000565	CcSEcCtD
Sulindac—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.82e-05	0.000564	CcSEcCtD
Sulindac—Nausea—Sitagliptin—type 2 diabetes mellitus	7.82e-05	0.000564	CcSEcCtD
Sulindac—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000564	CcSEcCtD
Sulindac—Asthenia—Glyburide—type 2 diabetes mellitus	7.81e-05	0.000564	CcSEcCtD
Sulindac—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000563	CcSEcCtD
Sulindac—Anorexia—Metformin—type 2 diabetes mellitus	7.8e-05	0.000563	CcSEcCtD
Sulindac—Urticaria—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.00056	CcSEcCtD
Sulindac—Alopecia—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000559	CcSEcCtD
Sulindac—Fatigue—Valsartan—type 2 diabetes mellitus	7.74e-05	0.000559	CcSEcCtD
Sulindac—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.73e-05	0.000558	CcSEcCtD
Sulindac—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000557	CcSEcCtD
Sulindac—Oedema—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000557	CcSEcCtD
Sulindac—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000557	CcSEcCtD
Sulindac—Pruritus—Glyburide—type 2 diabetes mellitus	7.7e-05	0.000556	CcSEcCtD
Sulindac—Constipation—Valsartan—type 2 diabetes mellitus	7.68e-05	0.000554	CcSEcCtD
Sulindac—Fatigue—Orlistat—type 2 diabetes mellitus	7.65e-05	0.000552	CcSEcCtD
Sulindac—Hypotension—Metformin—type 2 diabetes mellitus	7.64e-05	0.000551	CcSEcCtD
Sulindac—Shock—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000548	CcSEcCtD
Sulindac—Chest pain—Losartan—type 2 diabetes mellitus	7.58e-05	0.000547	CcSEcCtD
Sulindac—Arthralgia—Losartan—type 2 diabetes mellitus	7.58e-05	0.000547	CcSEcCtD
Sulindac—Myalgia—Losartan—type 2 diabetes mellitus	7.58e-05	0.000547	CcSEcCtD
Sulindac—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.57e-05	0.000546	CcSEcCtD
Sulindac—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000545	CcSEcCtD
Sulindac—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000544	CcSEcCtD
Sulindac—Rash—Bromocriptine—type 2 diabetes mellitus	7.51e-05	0.000542	CcSEcCtD
Sulindac—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.5e-05	0.000541	CcSEcCtD
Sulindac—Tension—Ramipril—type 2 diabetes mellitus	7.49e-05	0.00054	CcSEcCtD
Sulindac—Discomfort—Losartan—type 2 diabetes mellitus	7.49e-05	0.00054	CcSEcCtD
Sulindac—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000539	CcSEcCtD
Sulindac—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000538	CcSEcCtD
Sulindac—Headache—Bromocriptine—type 2 diabetes mellitus	7.46e-05	0.000538	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.45e-05	0.000538	CcSEcCtD
Sulindac—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000538	CcSEcCtD
Sulindac—Nervousness—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000535	CcSEcCtD
Sulindac—Anorexia—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000531	CcSEcCtD
Sulindac—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.34e-05	0.00053	CcSEcCtD
Sulindac—Paraesthesia—Metformin—type 2 diabetes mellitus	7.34e-05	0.00053	CcSEcCtD
Sulindac—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000528	CcSEcCtD
Sulindac—Dyspnoea—Metformin—type 2 diabetes mellitus	7.29e-05	0.000526	CcSEcCtD
Sulindac—Somnolence—Metformin—type 2 diabetes mellitus	7.27e-05	0.000525	CcSEcCtD
Sulindac—Oedema—Losartan—type 2 diabetes mellitus	7.26e-05	0.000524	CcSEcCtD
Sulindac—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.26e-05	0.000524	CcSEcCtD
Sulindac—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.26e-05	0.000524	CcSEcCtD
Sulindac—Hypotension—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.00052	CcSEcCtD
Sulindac—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.00052	CcSEcCtD
Sulindac—Dyspepsia—Metformin—type 2 diabetes mellitus	7.2e-05	0.00052	CcSEcCtD
Sulindac—Shock—Losartan—type 2 diabetes mellitus	7.15e-05	0.000516	CcSEcCtD
Sulindac—Urticaria—Valsartan—type 2 diabetes mellitus	7.13e-05	0.000515	CcSEcCtD
Sulindac—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.11e-05	0.000513	CcSEcCtD
Sulindac—Decreased appetite—Metformin—type 2 diabetes mellitus	7.11e-05	0.000513	CcSEcCtD
Sulindac—Tachycardia—Losartan—type 2 diabetes mellitus	7.09e-05	0.000512	CcSEcCtD
Sulindac—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000511	CcSEcCtD
Sulindac—Nausea—Bromocriptine—type 2 diabetes mellitus	7.07e-05	0.00051	CcSEcCtD
Sulindac—Fatigue—Metformin—type 2 diabetes mellitus	7.05e-05	0.000509	CcSEcCtD
Sulindac—Urticaria—Orlistat—type 2 diabetes mellitus	7.05e-05	0.000509	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.000507	CcSEcCtD
Sulindac—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.02e-05	0.000507	CcSEcCtD
Sulindac—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.02e-05	0.000506	CcSEcCtD
Sulindac—Asthenia—Gliclazide—type 2 diabetes mellitus	7.01e-05	0.000506	CcSEcCtD
Sulindac—Constipation—Metformin—type 2 diabetes mellitus	6.99e-05	0.000505	CcSEcCtD
Sulindac—Angioedema—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000503	CcSEcCtD
Sulindac—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.0005	CcSEcCtD
Sulindac—Anorexia—Losartan—type 2 diabetes mellitus	6.92e-05	0.0005	CcSEcCtD
Sulindac—Vomiting—Glyburide—type 2 diabetes mellitus	6.92e-05	0.000499	CcSEcCtD
Sulindac—Pruritus—Gliclazide—type 2 diabetes mellitus	6.92e-05	0.000499	CcSEcCtD
Sulindac—Malaise—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000497	CcSEcCtD
Sulindac—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000497	CcSEcCtD
Sulindac—Rash—Glyburide—type 2 diabetes mellitus	6.86e-05	0.000495	CcSEcCtD
Sulindac—Somnolence—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000495	CcSEcCtD
Sulindac—Dermatitis—Glyburide—type 2 diabetes mellitus	6.86e-05	0.000495	CcSEcCtD
Sulindac—Vertigo—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000495	CcSEcCtD
Sulindac—Syncope—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000494	CcSEcCtD
Sulindac—Leukopenia—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000493	CcSEcCtD
Sulindac—Headache—Glyburide—type 2 diabetes mellitus	6.82e-05	0.000492	CcSEcCtD
Sulindac—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.00049	CcSEcCtD
Sulindac—Hypotension—Losartan—type 2 diabetes mellitus	6.79e-05	0.00049	CcSEcCtD
Sulindac—Palpitations—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000487	CcSEcCtD
Sulindac—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.74e-05	0.000486	CcSEcCtD
Sulindac—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000484	CcSEcCtD
Sulindac—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000484	CcSEcCtD
Sulindac—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000483	CcSEcCtD
Sulindac—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.69e-05	0.000483	CcSEcCtD
Sulindac—Fatigue—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.00048	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.62e-05	0.000478	CcSEcCtD
Sulindac—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.62e-05	0.000477	CcSEcCtD
Sulindac—Convulsion—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000477	CcSEcCtD
Sulindac—Constipation—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000476	CcSEcCtD
Sulindac—Insomnia—Losartan—type 2 diabetes mellitus	6.57e-05	0.000474	CcSEcCtD
Sulindac—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000472	CcSEcCtD
Sulindac—Paraesthesia—Losartan—type 2 diabetes mellitus	6.52e-05	0.000471	CcSEcCtD
Sulindac—Urticaria—Metformin—type 2 diabetes mellitus	6.5e-05	0.000469	CcSEcCtD
Sulindac—Chest pain—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000469	CcSEcCtD
Sulindac—Arthralgia—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000469	CcSEcCtD
Sulindac—Myalgia—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000469	CcSEcCtD
Sulindac—Dyspnoea—Losartan—type 2 diabetes mellitus	6.48e-05	0.000467	CcSEcCtD
Sulindac—Nausea—Glyburide—type 2 diabetes mellitus	6.47e-05	0.000467	CcSEcCtD
Sulindac—Dizziness—Gliclazide—type 2 diabetes mellitus	6.46e-05	0.000466	CcSEcCtD
Sulindac—Somnolence—Losartan—type 2 diabetes mellitus	6.46e-05	0.000466	CcSEcCtD
Sulindac—Asthenia—Valsartan—type 2 diabetes mellitus	6.44e-05	0.000465	CcSEcCtD
Sulindac—Discomfort—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000463	CcSEcCtD
Sulindac—Dyspepsia—Losartan—type 2 diabetes mellitus	6.39e-05	0.000461	CcSEcCtD
Sulindac—Asthenia—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000459	CcSEcCtD
Sulindac—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000459	CcSEcCtD
Sulindac—Pruritus—Valsartan—type 2 diabetes mellitus	6.35e-05	0.000459	CcSEcCtD
Sulindac—Decreased appetite—Losartan—type 2 diabetes mellitus	6.31e-05	0.000456	CcSEcCtD
Sulindac—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000455	CcSEcCtD
Sulindac—Pruritus—Orlistat—type 2 diabetes mellitus	6.28e-05	0.000453	CcSEcCtD
Sulindac—Fatigue—Losartan—type 2 diabetes mellitus	6.26e-05	0.000452	CcSEcCtD
Sulindac—Oedema—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000449	CcSEcCtD
Sulindac—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000449	CcSEcCtD
Sulindac—Vomiting—Gliclazide—type 2 diabetes mellitus	6.22e-05	0.000449	CcSEcCtD
Sulindac—Constipation—Losartan—type 2 diabetes mellitus	6.21e-05	0.000448	CcSEcCtD
Sulindac—Rash—Gliclazide—type 2 diabetes mellitus	6.16e-05	0.000445	CcSEcCtD
Sulindac—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.16e-05	0.000444	CcSEcCtD
Sulindac—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000443	CcSEcCtD
Sulindac—Urticaria—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.000442	CcSEcCtD
Sulindac—Shock—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000442	CcSEcCtD
Sulindac—Headache—Gliclazide—type 2 diabetes mellitus	6.12e-05	0.000442	CcSEcCtD
Sulindac—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.00044	CcSEcCtD
Sulindac—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.1e-05	0.00044	CcSEcCtD
Sulindac—Tachycardia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000439	CcSEcCtD
Sulindac—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000438	CcSEcCtD
Sulindac—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000434	CcSEcCtD
Sulindac—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.99e-05	0.000432	CcSEcCtD
Sulindac—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.94e-05	0.000429	CcSEcCtD
Sulindac—Dizziness—Valsartan—type 2 diabetes mellitus	5.94e-05	0.000429	CcSEcCtD
Sulindac—Anorexia—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000428	CcSEcCtD
Sulindac—Dizziness—Orlistat—type 2 diabetes mellitus	5.87e-05	0.000423	CcSEcCtD
Sulindac—Asthenia—Metformin—type 2 diabetes mellitus	5.87e-05	0.000423	CcSEcCtD
Sulindac—Hypotension—Ramipril—type 2 diabetes mellitus	5.82e-05	0.00042	CcSEcCtD
Sulindac—Nausea—Gliclazide—type 2 diabetes mellitus	5.81e-05	0.000419	CcSEcCtD
Sulindac—Pruritus—Metformin—type 2 diabetes mellitus	5.79e-05	0.000418	CcSEcCtD
Sulindac—Urticaria—Losartan—type 2 diabetes mellitus	5.77e-05	0.000416	CcSEcCtD
Sulindac—Body temperature increased—Losartan—type 2 diabetes mellitus	5.74e-05	0.000414	CcSEcCtD
Sulindac—Vomiting—Valsartan—type 2 diabetes mellitus	5.71e-05	0.000412	CcSEcCtD
Sulindac—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.00041	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000409	CcSEcCtD
Sulindac—Rash—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000409	CcSEcCtD
Sulindac—Dermatitis—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000408	CcSEcCtD
Sulindac—Vomiting—Orlistat—type 2 diabetes mellitus	5.64e-05	0.000407	CcSEcCtD
Sulindac—Insomnia—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000407	CcSEcCtD
Sulindac—Headache—Valsartan—type 2 diabetes mellitus	5.63e-05	0.000406	CcSEcCtD
Sulindac—Diarrhoea—Metformin—type 2 diabetes mellitus	5.6e-05	0.000404	CcSEcCtD
Sulindac—Rash—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000404	CcSEcCtD
Sulindac—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000404	CcSEcCtD
Sulindac—Dermatitis—Orlistat—type 2 diabetes mellitus	5.59e-05	0.000403	CcSEcCtD
Sulindac—Headache—Orlistat—type 2 diabetes mellitus	5.56e-05	0.000401	CcSEcCtD
Sulindac—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000401	CcSEcCtD
Sulindac—Asthenia—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.0004	CcSEcCtD
Sulindac—Somnolence—Ramipril—type 2 diabetes mellitus	5.54e-05	0.0004	CcSEcCtD
Sulindac—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000396	CcSEcCtD
Sulindac—Pruritus—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.000394	CcSEcCtD
Sulindac—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000391	CcSEcCtD
Sulindac—Dizziness—Metformin—type 2 diabetes mellitus	5.41e-05	0.00039	CcSEcCtD
Sulindac—Fatigue—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000387	CcSEcCtD
Sulindac—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.35e-05	0.000386	CcSEcCtD
Sulindac—Nausea—Valsartan—type 2 diabetes mellitus	5.33e-05	0.000385	CcSEcCtD
Sulindac—Constipation—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000384	CcSEcCtD
Sulindac—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000381	CcSEcCtD
Sulindac—Nausea—Orlistat—type 2 diabetes mellitus	5.27e-05	0.00038	CcSEcCtD
Sulindac—Asthenia—Losartan—type 2 diabetes mellitus	5.21e-05	0.000376	CcSEcCtD
Sulindac—Vomiting—Metformin—type 2 diabetes mellitus	5.2e-05	0.000375	CcSEcCtD
Sulindac—Rash—Metformin—type 2 diabetes mellitus	5.16e-05	0.000372	CcSEcCtD
Sulindac—Dermatitis—Metformin—type 2 diabetes mellitus	5.15e-05	0.000372	CcSEcCtD
Sulindac—Pruritus—Losartan—type 2 diabetes mellitus	5.14e-05	0.000371	CcSEcCtD
Sulindac—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.13e-05	0.00037	CcSEcCtD
Sulindac—Headache—Metformin—type 2 diabetes mellitus	5.12e-05	0.00037	CcSEcCtD
Sulindac—Dizziness—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000368	CcSEcCtD
Sulindac—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000368	CcSEcCtD
Sulindac—Diarrhoea—Losartan—type 2 diabetes mellitus	4.97e-05	0.000359	CcSEcCtD
Sulindac—Urticaria—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000357	CcSEcCtD
Sulindac—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000355	CcSEcCtD
Sulindac—Vomiting—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000354	CcSEcCtD
Sulindac—Rash—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000351	CcSEcCtD
Sulindac—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000351	CcSEcCtD
Sulindac—Nausea—Metformin—type 2 diabetes mellitus	4.86e-05	0.000351	CcSEcCtD
Sulindac—Headache—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000349	CcSEcCtD
Sulindac—Dizziness—Losartan—type 2 diabetes mellitus	4.8e-05	0.000347	CcSEcCtD
Sulindac—Vomiting—Losartan—type 2 diabetes mellitus	4.62e-05	0.000333	CcSEcCtD
Sulindac—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000331	CcSEcCtD
Sulindac—Nausea—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000331	CcSEcCtD
Sulindac—Rash—Losartan—type 2 diabetes mellitus	4.58e-05	0.00033	CcSEcCtD
Sulindac—Dermatitis—Losartan—type 2 diabetes mellitus	4.58e-05	0.00033	CcSEcCtD
Sulindac—Headache—Losartan—type 2 diabetes mellitus	4.55e-05	0.000328	CcSEcCtD
Sulindac—Asthenia—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000322	CcSEcCtD
Sulindac—Pruritus—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000318	CcSEcCtD
Sulindac—Nausea—Losartan—type 2 diabetes mellitus	4.31e-05	0.000311	CcSEcCtD
Sulindac—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000308	CcSEcCtD
Sulindac—Dizziness—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000297	CcSEcCtD
Sulindac—Vomiting—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000286	CcSEcCtD
Sulindac—Rash—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000283	CcSEcCtD
Sulindac—Dermatitis—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000283	CcSEcCtD
Sulindac—Headache—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000282	CcSEcCtD
Sulindac—Nausea—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000267	CcSEcCtD
Sulindac—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	3.16e-06	2.59e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	3.14e-06	2.58e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	3.14e-06	2.58e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.14e-06	2.57e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOB—type 2 diabetes mellitus	3.13e-06	2.57e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.11e-06	2.55e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.11e-06	2.55e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	3.09e-06	2.54e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	3.08e-06	2.53e-05	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—type 2 diabetes mellitus	3.06e-06	2.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—type 2 diabetes mellitus	3.06e-06	2.51e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	3.03e-06	2.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.03e-06	2.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.03e-06	2.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.02e-06	2.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AGT—type 2 diabetes mellitus	3.01e-06	2.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—type 2 diabetes mellitus	3e-06	2.46e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	3e-06	2.46e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—LPL—type 2 diabetes mellitus	2.99e-06	2.46e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.99e-06	2.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	2.98e-06	2.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	2.98e-06	2.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	2.98e-06	2.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.96e-06	2.43e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.96e-06	2.43e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.96e-06	2.43e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.96e-06	2.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—type 2 diabetes mellitus	2.95e-06	2.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—type 2 diabetes mellitus	2.95e-06	2.42e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTGF—type 2 diabetes mellitus	2.93e-06	2.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.92e-06	2.4e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	2.9e-06	2.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—type 2 diabetes mellitus	2.89e-06	2.37e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.88e-06	2.37e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.87e-06	2.35e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.86e-06	2.35e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	2.84e-06	2.33e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	2.84e-06	2.33e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.83e-06	2.33e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	2.83e-06	2.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.81e-06	2.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	2.81e-06	2.3e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	2.81e-06	2.3e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	2.8e-06	2.3e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	2.79e-06	2.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.79e-06	2.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.76e-06	2.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.75e-06	2.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.75e-06	2.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.74e-06	2.25e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	2.73e-06	2.24e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.72e-06	2.24e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NFKB1—type 2 diabetes mellitus	2.72e-06	2.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.7e-06	2.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—type 2 diabetes mellitus	2.7e-06	2.22e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	2.7e-06	2.22e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	2.7e-06	2.21e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	2.7e-06	2.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.69e-06	2.21e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.67e-06	2.19e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	2.66e-06	2.18e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	2.65e-06	2.17e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.64e-06	2.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.64e-06	2.16e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	2.63e-06	2.16e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.62e-06	2.15e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	2.62e-06	2.15e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.62e-06	2.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	2.61e-06	2.14e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCG—type 2 diabetes mellitus	2.58e-06	2.12e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	2.58e-06	2.12e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	2.57e-06	2.11e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS2—type 2 diabetes mellitus	2.56e-06	2.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	2.55e-06	2.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—SRC—type 2 diabetes mellitus	2.53e-06	2.08e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—type 2 diabetes mellitus	2.52e-06	2.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CALM1—type 2 diabetes mellitus	2.52e-06	2.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—type 2 diabetes mellitus	2.51e-06	2.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	2.51e-06	2.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.48e-06	2.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOA1—type 2 diabetes mellitus	2.48e-06	2.03e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	2.45e-06	2.01e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	2.45e-06	2.01e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.44e-06	2e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	2.44e-06	2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.44e-06	2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.44e-06	2e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.43e-06	2e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.43e-06	2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.43e-06	1.99e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	2.4e-06	1.97e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	2.39e-06	1.96e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	2.39e-06	1.96e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-06	1.95e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	2.38e-06	1.95e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.35e-06	1.93e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	2.34e-06	1.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—type 2 diabetes mellitus	2.34e-06	1.92e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—SRC—type 2 diabetes mellitus	2.34e-06	1.92e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	2.33e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.33e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	2.32e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	2.32e-06	1.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	2.32e-06	1.91e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.32e-06	1.91e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.32e-06	1.9e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.31e-06	1.89e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	1.89e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.27e-06	1.86e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.27e-06	1.86e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	2.26e-06	1.86e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—type 2 diabetes mellitus	2.26e-06	1.85e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	2.26e-06	1.85e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	2.24e-06	1.84e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS1—type 2 diabetes mellitus	2.24e-06	1.84e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GNB3—type 2 diabetes mellitus	2.23e-06	1.83e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.23e-06	1.83e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	2.22e-06	1.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—type 2 diabetes mellitus	2.22e-06	1.82e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	2.22e-06	1.82e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	2.21e-06	1.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.21e-06	1.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.21e-06	1.82e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAT—type 2 diabetes mellitus	2.19e-06	1.79e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.18e-06	1.79e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	2.17e-06	1.78e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	2.14e-06	1.76e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—type 2 diabetes mellitus	2.14e-06	1.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOB—type 2 diabetes mellitus	2.12e-06	1.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	2.11e-06	1.73e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	2.11e-06	1.73e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	2.1e-06	1.72e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.09e-06	1.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—type 2 diabetes mellitus	2.09e-06	1.71e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.09e-06	1.71e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.08e-06	1.71e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.08e-06	1.71e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.08e-06	1.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.08e-06	1.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	2.08e-06	1.7e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.08e-06	1.7e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	2.07e-06	1.7e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT2—type 2 diabetes mellitus	2.07e-06	1.7e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.07e-06	1.69e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—type 2 diabetes mellitus	2.05e-06	1.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.05e-06	1.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.03e-06	1.66e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.03e-06	1.66e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	2e-06	1.64e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2e-06	1.64e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.99e-06	1.63e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.98e-06	1.63e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.98e-06	1.63e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.98e-06	1.63e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.98e-06	1.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	1.97e-06	1.61e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.96e-06	1.61e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.93e-06	1.58e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.91e-06	1.56e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.9e-06	1.56e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.9e-06	1.56e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.89e-06	1.55e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.88e-06	1.54e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.88e-06	1.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-06	1.54e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.87e-06	1.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-06	1.53e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.86e-06	1.53e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.84e-06	1.51e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.84e-06	1.51e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-06	1.5e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.83e-06	1.5e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.83e-06	1.5e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.81e-06	1.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.81e-06	1.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.81e-06	1.48e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.79e-06	1.47e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.79e-06	1.47e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-06	1.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-06	1.44e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.73e-06	1.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.72e-06	1.41e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.71e-06	1.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—type 2 diabetes mellitus	1.71e-06	1.4e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.7e-06	1.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.68e-06	1.38e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.65e-06	1.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-06	1.34e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.62e-06	1.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.59e-06	1.31e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.59e-06	1.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—type 2 diabetes mellitus	1.57e-06	1.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	1.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	1.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—type 2 diabetes mellitus	1.57e-06	1.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—type 2 diabetes mellitus	1.56e-06	1.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.56e-06	1.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.56e-06	1.28e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.55e-06	1.27e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.53e-06	1.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.49e-06	1.22e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.48e-06	1.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-06	1.2e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.46e-06	1.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—type 2 diabetes mellitus	1.45e-06	1.19e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—type 2 diabetes mellitus	1.45e-06	1.19e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.45e-06	1.19e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.44e-06	1.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-06	1.18e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.42e-06	1.16e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-06	1.15e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-06	1.15e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.39e-06	1.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.39e-06	1.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.38e-06	1.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.35e-06	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.33e-06	1.09e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	1.05e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.28e-06	1.05e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	1.04e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	1.04e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.25e-06	1.03e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.24e-06	1.02e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.22e-06	1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.21e-06	9.95e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.19e-06	9.79e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.19e-06	9.75e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	9.64e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-06	9.55e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-06	9.05e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	8.5e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	8.35e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	8.33e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—type 2 diabetes mellitus	9.36e-07	7.68e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.31e-07	7.64e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	9.11e-07	7.48e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.91e-07	7.31e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	8.91e-07	7.31e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—type 2 diabetes mellitus	8.64e-07	7.09e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.15e-07	6.68e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	7.24e-07	5.94e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	6.42e-07	5.27e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—type 2 diabetes mellitus	5.85e-07	4.8e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.09e-07	3.36e-06	CbGpPWpGaD
